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ABSTRACT. We have shown previously that iV-methyl-D,L-
aspartate (NMDA) and kainate, two neuroexcitatory amino
acids acting through distinct receptors, may induce the release
of GnRH from hypothalamic explants. However, that effect
could have no physiological significance, since very high concen-
trations (50 mM) of NMDA and kainate were required. Here,
using agents blocking the activation of receptors to neuroexci-
tatory amino acids, we evaluated their possible physiological
involvement in the pulsatile release of GnRH from the hypo-
thalamus of 50-day-old male rats in vitro. In control conditions
(10 nM glycine and 1 mM Mg2"1"), the release of GnRH in 7.5-
min fractions collected for 2-4 h showed an obvious pulsatile
pattern. The mean (±1 SD) interval between pulses, identified
by PULSAR program, was 34.3 ± 11.4 min. The stimulation of
GnRH release by NMDA (50 mM) added to the medium for 7.5
min could be blocked reversibly in the presence of MK-801 (100
ixM) using medium without glycine or enriched with Mg2"1" (2
mM). The endogenous pulses of GnRH secretion were abolished
in the presence of MK-801 or using increased Mg2* concentra-
tions as well as in the absence of glycine. In contrast, pulsatile
release of GnRH was not affected in the presence of 6,7-dinitro-
quinoxaline-2,3-dione (0.1 mM), a selective inhibitor of kainate
and quisqualate receptors which suppressed the increase in
GnRH release induced by kainate (50 mM) without affecting the
response to NMDA. These data indicate that the physiological
mechanism of pulsatile GnRH secretion in the hypothalamus
may involve endogenous neuroexcitatory factors acting through
NMDA-sensitive receptors. {Endocrinology 125: 1090-1096,
1989)
THE AGONISTS of neuroexcitatory amino acids(NEAA), such as iV-methyl-D,L-aspartate (NMDA)
and kainate, activate hypothalamic receptors possibly
involved in the control of anterior pituitary hormone
secretion, including LH (1-5). Chronic intermittent ad-
ministration of NMDA mimics the effects of pulsatile
GnRH secretion on LH and induces sexual maturation
(6, 7). While those observations could result from phar-
macological effects, the suppression of pulsatile LH se-
cretion in vivo by a specific antagonist of NMDA recep-
tors (8) has provided indirect evidence of a possible
physiological role for those receptors.
Recently, we showed that the release of GnRH from
hypothalamic explants in vitro could be directly stimu-
lated in the presence of kainate and NMDA, although
very high concentrations were required (9). Since the
release of GnRH in vitro had been shown to be pulsatile
in our experimental conditions (10,11), the present study
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was designed to examine directly if endogenous neuro-
regulatory substrates acting through NMDA or kainate
receptors might control pulsatile GnRH secretion.
Therefore, antagonists of NMDA- and kainate-sensitive
receptors were used to block a putative physiological
mechanism involving those receptors.
Materials and Methods
Animals and incubation procedure
The retrochiasmatic hypothalamus of 50-day-old male Wis-
tar rats (Janssens, Beerse, Belgium) was dissected and studied
individually in vitro, as previously described (9-11). For each
experiment, 12 static incubation chambers were used, each
containing 1 hypothalamic explant in 0.5 ml culture medium,
which was renewed every 7.5 min for 2.5-4 h.
While our previous experiments (9) were carried out using
Dulbecco's Modified Eagle's Medium, the present data were
obtained using Eagle's Minimum Essential Medium modified
with Earle's salts (Flow, MacLean, VA), which is available
without glycine, aspartate, and glutamate and contains 1.8 mM
Ca2+. In control conditions, Minimum Essential Medium was
enriched with glycine, magnesium, and glucose to achieve final
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bacitracine 20 nM (Sigma, St. Louis, MO) was added to prevent
degradation of GnRH by hypothalamic peptidases.
RIA of GnRH and pulse analysis
Using the highly specific RR-5 anti-GnRH antiserum gen-
erously supplied by Dr. A. Root (St. Petersburg, FL), GnRH
was measured in duplicate on 0.1-ml samples from the 0.5-ml
fractions collected every 7.5 min, as described previously (10,
11). The intra- and interassay coefficients of variations of both
the explant incubation and the RIA procedure were 14% and
18%, respectively. The sensitivity of the assay varied between
0.5 and 1 pg/tube, so that the limit of detection was 5 pg/7.5-
min fraction, which was the value assigned to data below that
limit. The standard curves for the RIA of GnRH were prepared
in the medium used for incubation of the hypothalamic ex-
plants, and no interaction was found between the test sub-
stances used and the binding of radiolabeled GnRH to the
antiserum. The pH was controlled using an indicator (phenol
red) in the medium and brought to neutrality (7.4) when
necessary.
The occurrence of significant pulses of GnRH release was
estimated using an IBM-PC compatible version (12) of the
Pulsar program (13). The 14% coefficient of variation described
above was used as the B coefficient to determine the assay SD.
The cutoff criteria (G) for peak identification were calculated
empirically, d was 2.5, and G2 2.0. The vast majority of pulses
observed were single data point peaks. Pulse amplitude was
calculated by the difference between the peak value and the
smoothed baseline value determined at the same time by the
computer program. Pulse frequency was calculated using the
intervals between pulses observed within the study period of
each single hypothalamus. To estimate pulse frequency when
no pulse or only one pulse was released from an explant, the
interval was considered to be at least equal to the total length
or half the length of the period studied, respectively.
Test substances
Two different agonists of NEAA, NMDA and kainate
(Sigma), were used at a 50-mM concentration because it con-
sistently resulted in a submaximal release of GnRH which was
less likely to be neurotoxic than at the plateau of the response
(9). MK-801, a noncompetitive inhibitor of NMDA receptors
(14), was generously supplied by Merck, Sharp, and Dohme
Research Laboratories (Rahway, NJ) and used at concentra-
tions of 0.01 and 100 /zM. Increased Mg2+ concentrations (2
mM) were also used as a noncompetitive inhibition to NMDA
receptors (15, 16). Glycine-free medium was used to suppress
the facilitatory role played by glycine at the allosteric site of
the NMDA receptor (17). DNQX (Tocris Neuramin, Buckhurst
Hill, United Kingdom), a selective antagonist of kainate and
quisqualate receptors (18), was used at a 0.1-mM concentration.
Veratridine (50 /*M; Sigma), a depolarizing agent, was used to
evaluate the GnRH release induced by depolarization (10,11).
Study protocols
Using six individual hypothalami, veratridine-induced
GnRH release was evaluated before and after exposure to
NMDA. The agonist was used twice at the same concentration
of 50 mM or at increasing concentrations (50 and 100 mM).
In a second set of experiments, GnRH release from 12
individual hypothalami was studied before and after incubation
for 7.5 min in the presence of kainate or NMDA (50 mM). This
study was repeated using medium enriched with MK-801 (0.01
or 100 fiM), Mg2+ (2 mM), 6,7-dinitro-quinoxaline-2,3-dione
(DNQX; 0.1 mM), or glycine-free culture medium. The hypo-
thalami were exposed to those modified culture medium for two
consecutive 7.5-min periods, immediately before and during
stimulation by NMDA or kainate. After using MK-801 or Mg2+
as antagonists, the effect of NMDA on GnRH secretion was
reevaluated in control conditions to study the reversibility of
the antagonistic effects. The GnRH release induced by veratri-
dine was also studied before, during, and after exposure to MK-
801 or increased Mg2+ concentrations in order to rule out a
nonspecific effect of those antagonists on tissue viability.
In a third set of experiments, the spontaneous pattern of
GnRH secretion was studied for 2.5-4 h in the absence of
NMDA or kainate. During each experiment, 6 hypothalami
were incubated in the control conditions described above, while
6 hypothalami were incubated in the presence of MK-801 (0.01
or 100 HM), Mg2+ (2 mM), or DNQX (0.1 mM) or using glycine-
free medium. Since these experiments were performed twice, a
total of 60 explants were studied in control conditions, while
12 explants were studied using each of the antagonists of NEAA
receptors. After having discarded the data obtained using ex-
plants that happened to be fragmented or accidentally shaken
before termination of the experiment, a total of 42 control
explants were studied, while 9-10 explants were studied in each
of the antagonist conditions.
Statistical analysis
Paired Student's t test was used to calculate the significance
of differences in basal and NMDA- or veratridine-induced
GnRH release, evaluated twice contiguously within an in vitro
experiment. The significance of differences in distribution of
GnRH interpulse intervals and differences in pulse amplitude
between the antagonist conditions were calculated, respec-
tively, using Kolmogorov-Smirnov's test and Scheffe's test for
multiple comparison with analysis of variance (19).
Results
As shown in Fig. 1 (left panel), veratridine induced an
increment in GnRH secretion. This increment (mean ±
1 SD) was, respectively, 18.8 ± 8.7 and 21.1 ± 12.1 pg
before and after repeated exposure to 50 mM NMDA,
which elicited two pulses of GnRH release. In contrast,
after a challenge using 100 mM NMDA, there was a
significant reduction (4.7 ± 3.2 vs. 16.2 ± 8.4 pg; P <
0.01) of the responsiveness to veratridine (Fig. 1, right
panel).
As shown in Fig. 2 both kainate and NMDA (50 mM)
elicited a significant increase in GnRH secretion in vitro,
confirming our previous observations (9). At a 0.01-/uM
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FlG. 1. Individual profiles of GnRH re-
lease from six hypothalamic explants
challenged using veratridine before and
after exposure to NMDA, twice at the
same concentrations (left panel) or at
increasing concentrations (right panel).
The dashed lines indicate the detection
limit of the assay.
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FIG. 2. Release of GnRH (mean ± 1 SD)
from 12 hypothalamic explants in vitro
induced by a 7.5-min exposure to 50 mM
NMDA (•) or kainate (A) in control
conditions (left panel) or in the presence
of inhibitors of the receptors to those
NEAA. The dashed line indicates the












of NMDA, while the response to kainate was still present.
At a higher concentration (100 /IM), MK-801 blocked the
effects of both NMDA and kainate. Increased concentra-
tions of Mg2+ (2 mM) or glycine-free medium resulted in
a selective suppression of the response to NMDA without
affecting the response to kainate. On the contrary, the
increase in GnRH release induced by kainate was no
longer observed in the presence of 0.1 mM DNQX, which
2 3 1 2 3 1 2 3 1 2 3 1 2 3
7.5-min fractions
did not affect the response to NMDA.
As shown in Table 1, the increment in GnRH release
induced by 50 mM NMDA as well as that induced by 50
nM veratridine were significantly reduced in the presence
of 2 mM Mg2+ or 100 nM MK-801. When retested under
control conditions, the response to NMDA or veratridine
was not significantly different from pretreatment values.
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TABLE 1. Reversibility of the inhibitory effects of antagonists of
NMDA receptors on NMDA- and veratridine-induced release of GnRH
from hypothalamic explants in vitro (n = 12)
Before exposure to Mg2* (2 mM)
In the presence of Mg2* (2 mM)
In control conditions after Mg2*
(2 mM)
Before exposure to MK-801 (100
In the presence of MK-801 (100





















Values are the mean ± 1 SD.
" P < 0.001 vs. pretreatment value.
h P < 0.005 vs. pretreatment value.
c P = NS vs. pretreatment value.
thalamic explants was pulsatile (Figs. 3 and 4, upper
panels). The mean ± 1 SD interval between GnRH pulses
was 34.3 ± 11.4 min (n = 164), and the mean amplitude
of GnRH pulses was 14.0 ± 5.8 pg (n = 236). Similar
profiles of GnRH secretion were observed regardless of
the basal secretory level of GnRH; the trough values
were below the limit of detection (5 pg/7.5 min) in some
explants or above 10 pg/7.5 min in others.
In the presence of 0.01 »M MK-801 (Fig. 3, middle
panel), the frequency of GnRH secretory pulses (mean
{ I
interval ± 1 SD, 49.4 ± 27.6 min; n = 17) was significantly
lower (P < 0.01) than that under control conditions.
There was an important variability in the frequency of
GnRH pulses, ranging between one and six pulses during
a 3-h period. In the presence of 100 fxM MK-801 (Fig. 3,
lower panel), pulsatile GnRH release was almost com-
pletely abolished. Increased concentrations of Mg2+ or
the absence of glycine in culture medium resulted in a
suppression of the pulsatile pattern of GnRH release
(Fig. 4). In the presence of 0.1 mM DNQX (Fig. 4, lower
panel), the interval between GnRH pulses was 39.3 ± 9.9
min, not significantly different from the control value. It
can also be seen in Figs. 3 and 4 that the basal secretory
level of GnRH was different from one explant to the
other under control conditions as well as in the presence
of antagonists of NMDA receptors.
As shown in Fig. 5, the frequency distribution of GnRH
interpulse intervals was similar in control conditions and
in the presence of DNQX, which antagonized kainate
and quisqualate receptors. A significantly greater inter-
val between GnRH pulses was observed in all the con-
ditions antagonizing NMDA receptors. There was no
significant difference in GnRH pulse amplitude between
the different conditions studied.
Discussion
Our observations provide a direct demonstration that
the hypothalamic mechanism of pulsatile GnRH secre-
tion may physiologically involve activation of the recep-
tors to NMDA. The physiological role of receptors to
NEAA in the control of LH secretion in the rat was
I j I I I I 1 I! I I I I
FlG. 3. Release of GnRH in 7.5-min
fractions collected for 3.5 h during in
vitro incubation of individual hypotha-
lamic explants in control conditions or
in the presence of MK-801 at two differ-
ent concentrations. The arrows denote
significant GnRH secretory pulses. The
dashed lines indicate the detection limit
of the assay.






/endo/article/125/2/1090/2532425 by guest on 11 M
ay 2021
1094 PULSATILE GnRH SECRETION AND NMDA RECEPTORS Endo • 1989
Vol 125 • No 2
30L
20.
I l l I l l l I I I I I I I
CONTROLS
60 120 '60 120 60 120
FlG. 4. Release of GnRH in 7.5-min fractions collected for 2.1 h during
in vitro incubation of individual hypothalamic explants in control
conditions, in the presence of DNQX or increased Mg2"1" concentrations,
or in the absence of glycine. The arrows denote significant GnRH
secretory pulses. The dashed lines indicate the detection limit of the
assay.
demonstrated recently by the suppression of LH pulsatile
release in vivo using AP5, a selective competitive antag-
onist of NMDA receptors (8). This study took advantage
of the finding that retrochiasmatic hypothalami exhibit
pulsatile GnRH in vitro (10, 11). This enabled us to
directly evaluate the role of NEAA in GnRH release.
Since we showed previously that exogenous agonists such
as kainate and NMDA stimulated GnRH release (9),
emphasis was put on the effects of antagonists on the
endogenous mechanism controlling GnRH secretion.
The question of whether antagonists of NEAA would
affect GnRH secretion was particularly important, be-
cause extremely high concentrations of kainate or
NMDA were required to elicit an increase in GnRH
secretion in vitro (9). A tentative explanation for the
very high concentrations of agonists required was the
age-related variations in the sensitivity of LH increase
in response to NMDA, which was shown to increase at
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FlG. 5. Frequency distribution of the intervals between GnRH pulses
(left panel) and mean ± 1 SD amplitude of GnRH pulses (right panel)
in control conditions or in different conditions blocking the activation
of receptors to NEAA. The number of pulses used to calculate the
mean amplitude is given in parentheses. The stars denote significant
differences (P < 0.05) us. controls.
and 60 days of age (20). The concentration of agonist
was a matter of great concern, because kainate and
NMDA were shown to induce neuronal lesions at con-
centrations much lower than those used in our experi-
ments (21). Since we found previously that the response
to 50 mM NMDA could be obtained repetitively in our
experimental conditions (9), we assumed that no neuro-
toxic effect occurred at the submaximal concentration.
As shown in this paper, the unaltered capacity of vera-
tridine to elicit GnRH release after exposure to 50 mM
NMDA provides further support for that hypothesis.
However, a 2-fold higher NMDA concentration (100 mM)
resulted in a reduction of the subsequent response to
veratridine. This indicated that a 100-mM concentration
of NMDA could have neurotoxic effects under our con-
ditions. In accordance with studies on LH in vivo (1), we
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and neurotoxic concentrations of NEAA in vitro.
According to our previous observations using agonists
of NEAA (9), both kainate and NMDA receptors could
be involved in the control of GnRH release. Using selec-
tive antagonists, such as DNQX, for kainate receptors
(18), it has been shown in this paper that NMDA recep-
tors may play a physiological role, while kainate recep-
tors have no obvious importance to the physiological
mechanism controlling GnRH secretion. The data ob-
tained using MK-801, a noncompetitive antagonist of
NMDA receptors (14), were somewhat conflicting, since
a 0.01-juM concentration blocked the effect of 50 mM
NMDA, while a 100-/xM concentration was required to
suppress pulsatile GnRH release. This may be explained
by the use-dependent property of MK-801 (22), which
means that the antagonistic activity is a direct function
of the concentration of the agonist acting at the receptor
level. It is conceivable that the concentrations of endog-
enous NEAA activating the receptors to NMDA are far
below the 50-mM concentration of NMDA used in our
experiments. The very high concentrations of kainate
used may also account for the inhibition of kainate-
induced GnRH release by high concentrations of MK-
801, which is known as a specific antagonist of NMDA
receptors (14). A mediation of kainate effects through
the receptors sensitive to NMDA is unlikely, since kain-
ate effects were abolished by DNQX but not by increased
Mg2+ concentrations or the absence of glycine.
The reversibility of the blocking effect of Mg2* or MK-
801 on the GnRH release induced by NMDA or veratri-
dine indicates that their antagonistic effect does not
result from an impaired viability of the explant. The
significant reduction of the GnRH response to veratri-
dine by antagonists of NMDA receptors is particularly
interesting because it suggests that the interaction be-
tween NEAA and the GnRH axon is located at a presyn-
aptic site more distal than those depolarized by veratri-
dine.
The NMDA receptors exhibit the unique feature of
being regulated by Mg2+ and glycine concentrations.
Increased Mg2+ concentrations block the NMDA ionic
channel in a noncompetitive and voltage-sensitive man-
ner (15, 16). While such an inhibitory effect may occur
at micromolar concentrations of Mg2"1" in some experi-
mental conditions (23), pulsatile GnRH release in vitro
could be observed in the presence of a physiological
concentration of 1 mM Mg2+. However, a 2-fold increase
in Mg2+ concentration was sufficient to obtain a marked
inhibition of pulsatile GnRH secretion. It cannot be
excluded that variations in intrahypothalamic Mg2+ con-
centrations participate in the regulation of GnRH secre-
tion.
It was shown recently that glycine, at concentrations
as low as 10 nM, could potentiate the response to NMDA
in a voltage-independent manner through an allosteric
site at the NMDA receptor level (17). We found previ-
ously that the GnRH release elicited by NMDA was
maximal in the presence of 10 nM glycine and less using
higher glycine concentrations (9). A possible influence of
glycine on the GnRH pulse-generating system in the
hypothalamus was also suggested by the regular occur-
rence of GnRH secretory pulses shown here in the pres-
ence of 10 nM glycine, while using medium containing
0.4 mM glycine, a more variable pattern of pulsatile
GnRH release was observed in our previous studies (10,
11). When the facilitatory role of glycine at the NMDA
receptor level was abolished by using glycine-free me-
dium, pulsatile GnRH release was inhibited. This might
suggest that glycine plays a regulatory role on the mech-
anism of pulsatile GnRH release. Also, our data empha-
size the importance of the nature of culture medium for
studying pulsatile GnRH release in vitro.
Recently, Cicero et al. (20) showed that the sensitivity
of LH to NMDA administration in vivo increased mark-
edly between 15 and 25 days of age in the male rat.
Interestingly, this period is coincident with an increase
in the frequency of pulsatile GnRH release in vitro (10).
The possible role of NMDA receptors in the central
mechanism driving sexual development is also suggested
by the induction of puberty during chronic intermittent
administration of NMDA to prepubertal female rats (7)
and male monkeys (6). Our experimental model provides
a direct means of studying the involvement of NMDA
receptors in the developmental changes in pulsatile
GnRH secretion.
This study provides additional evidence that the hy-
pothalamus, deafferented from the preoptic area and the
rest of the brain, is capable of generating GnRH secretory
pulses. Since most cell bodies of GnRH neurons are
located in the prechiasmatic region (24), our observations
support the concept that the GnRH pulse generator
would be 1) one or several neuronal systems distinct
from the GnRH neuron itself, 2) located in the retro-
chiasmatic hypothalamus, 3) capable of autonomous ac-
tivity independent of extrahypothalamic structures, and
4) capable of modulating presynaptically the secretory
activity of the GnRH axon through receptors sensitive
to NMDA.
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